Literature DB >> 16709533

Probiotic lactobacilli and bacteraemia in Stockholm.

Asa Sullivan1, Carl Erik Nord.   

Abstract

The objective of the present study was to determine the incidence of lactobacilli-induced bacteraemia in Stockholm, Sweden, between January 1998 and March 2004, and to identify the possible presence of probiotic strains. Isolated strains were checked for growth on selective lactobacilli-agar and the biochemical profiles were determined. The lactobacilli strains were further analysed with molecular methodologies to ascertain eventual similarities with the probiotic strains Lactobacillus paracasei subsp. paracasei F19 (LMG P 17806), Lactobacillus acidophilus NCFB 1748 and Lactobacillus rhamnosus GG (ATCC 53103). The minimum inhibitory concentrations of selected antimicrobial agents were determined by the agar dilution method. The incidence of bacteraemia cases caused by lactobacilli remained at the same level during the study period and constituted to <1% of the total number of bacteraemia cases each y. L. paracasei subsp. paracasei F19, L. acidophilus NCFB 1748 and L. rhamnosus GG were not identified in any of the samples.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709533     DOI: 10.1080/00365540500449826

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  10 in total

1.  Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.

Authors:  Alla Aroutcheva; Julie Auclair; Martin Frappier; Mathieu Millette; Karen Lolans; Danielle de Montigny; Serge Carrière; Stephen Sokalski; William E Trick; Robert A Weinstein
Journal:  Probiotics Antimicrob Proteins       Date:  2016-03       Impact factor: 4.609

Review 2.  Intestinal microbiota and blue baby syndrome: probiotic therapy for term neonates with cyanotic congenital heart disease.

Authors:  Collin L Ellis; John C Rutledge; Mark A Underwood
Journal:  Gut Microbes       Date:  2010 Nov-Dec

Review 3.  Risk and safety of probiotics.

Authors:  Shira Doron; David R Snydman
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

Review 4.  Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature.

Authors:  Simone Meini; Raffaele Laureano; Lucia Fani; Carlo Tascini; Angelo Galano; Alberto Antonelli; Gian Maria Rossolini
Journal:  Infection       Date:  2015-05-30       Impact factor: 3.553

Review 5.  Impact of probiotics on necrotizing enterocolitis.

Authors:  Mark A Underwood
Journal:  Semin Perinatol       Date:  2016-11-08       Impact factor: 3.300

6.  Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities.

Authors:  Shira Doron; Patricia L Hibberd; Barry Goldin; Cheleste Thorpe; Laura McDermott; David R Snydman
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

Review 7.  Probiotic sepsis in preterm neonates-a systematic review.

Authors:  Tithi Kulkarni; Swati Majarikar; Mangesh Deshmukh; Anitha Ananthan; Haribalakrishna Balasubramanian; Anthony Keil; Sanjay Patole
Journal:  Eur J Pediatr       Date:  2022-03-29       Impact factor: 3.183

8.  Altered Profiles of Gut Microbiota in Klebsiella pneumoniae-Induced Pyogenic Liver Abscess.

Authors:  Nan Chen; Zong-Xin Ling; Tong-Tong Jin; Ming Li; Sheng Zhao; Li-Shuang Zheng; Xin Xi; Lin-Lin Wang; Ying-Ying Chen; Yue-Liang Shen; Li-Ping Zhang; Shao-Cong Sun
Journal:  Curr Microbiol       Date:  2018-04-10       Impact factor: 2.188

Review 9.  Towards a better understanding of Lactobacillus rhamnosus GG--host interactions.

Authors:  Marijke E Segers; Sarah Lebeer
Journal:  Microb Cell Fact       Date:  2014-08-29       Impact factor: 5.328

10.  Acute Cholecystitis Complicated with Gallbladder Perforation and Peritonitis Caused by Vancomycin-resistant Lactobacillus paracasei.

Authors:  Christina Lee; Nicha Wongjarupong; Muthu Narayan; Anne C Melzer
Journal:  Cureus       Date:  2020-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.